Improvement of Intestinal Barrier Function, Gut Microbiota, and Metabolic Endotoxemia in Type 2 Diabetes Rats by Curcumin

Overview

Journal Bioengineered

Date 2021 Nov 25

PMID 34818970

Citations 26

Authors

Jingze Huang

Binbin Guan

Lijing Lin

Yanping Wang

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes mellitus (T2DM) is known as a complex genetic disease characterized by genetic and environmental factors. The imbalanced intestinal flora and intestinal mucosal barrier are considered to be related to T2DM. Curcumin has been proved to affect the progression of T2DM. T2DM animal was established by low-dose streptozotocin intraperitoneal injection combined with high-fat diet (HFD) feeding. Hematoxylin and eosin (HE) staining and transfer electron microscopy (TEM) were used to observe morphological changes of intestinal tissues of T2DM rats. Insulin and glucose tolerance tests were performed to investigate the influence of curcumin on blood glucose. Curcumin significantly improved the intestinal integrity, hyperglycemia and insulin resistance in diabetic rats. The metabolic endotoxemia induced by HFD in diabetic rats was inhibited remarkably. Curcumin reversed gut microbiota dysbiosis in diabetic rats caused by HFD. We demonstrated that curcumin could protect intestinal mucosal barrier, improve insulin resistance and reduce blood glucose in diabetic rats. This study might provide experimental evidence for the prevention and treatment in T2DM.

Citing Articles

Protective Role of Dietary Polyphenols in the Management and Treatment of Type 2 Diabetes Mellitus.

Martiniakova M, Sarocka A, Penzes N, Biro R, Kovacova V, Mondockova V Nutrients. 2025; 17(2).

PMID: 39861406 PMC: 11767469. DOI: 10.3390/nu17020275.

Integrating 16S rDNA and metabolomics to uncover the therapeutic mechanism of electroacupuncture in type 2 diabetic rats.

Yue Z, Xiang W, Duping D, Yuanyuan G, Xuanyi C, Juan L Front Microbiol. 2025; 15():1436911.

PMID: 39834366 PMC: 11743489. DOI: 10.3389/fmicb.2024.1436911.

Curcumin Mitigates Gut Dysbiosis and Enhances Gut Barrier Function to Alleviate Metabolic Dysfunction in Obese, Aged Mice.

Lamichhane G, Olawale F, Liu J, Lee D, Lee S, Chaffin N Biology (Basel). 2025; 13(12.

PMID: 39765622 PMC: 11726832. DOI: 10.3390/biology13120955.

The gut-brain-metabolic axis: exploring the role of microbiota in insulin resistance and cognitive function.

Abildinova G, Benberin V, Vochshenkova T, Afshar A, Mussin N, Kaliyev A Front Microbiol. 2024; 15:1463958.

PMID: 39659426 PMC: 11628546. DOI: 10.3389/fmicb.2024.1463958.

Curcumin mitigates polycystic ovary syndrome in mice by suppressing TLR4/MyD88/NF-κB signaling pathway activation and reducing intestinal mucosal permeability.

Yang Q, Wan Q, Wang Z Sci Rep. 2024; 14(1):29848.

PMID: 39617843 PMC: 11609283. DOI: 10.1038/s41598-024-81034-5.

References

Bulboaca A, Boarescu P, Bolboaca S, Blidaru M, Festila D, Dogaru G . Comparative Effect Of Curcumin Versus Liposomal Curcumin On Systemic Pro-Inflammatory Cytokines Profile, MCP-1 And RANTES In Experimental Diabetes Mellitus. Int J Nanomedicine. 2019; 14:8961-8972. PMC: 6873975. DOI: 10.2147/IJN.S226790. View

Monte S, Caruana J, Ghanim H, Sia C, Korzeniewski K, Schentag J . Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery. 2011; 151(4):587-93. DOI: 10.1016/j.surg.2011.09.038. View

Yu D, Cao Y, Mei X, Wang Y, Fan Z, Wang Y . Curcumin improves the integrity of blood-spinal cord barrier after compressive spinal cord injury in rats. J Neurol Sci. 2014; 346(1-2):51-9. DOI: 10.1016/j.jns.2014.07.056. View

Ghosh S, Bie J, Wang J, Ghosh S . Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR-/- mice--role of intestinal permeability and macrophage activation. PLoS One. 2014; 9(9):e108577. PMC: 4177397. DOI: 10.1371/journal.pone.0108577. View

Peng L, Shi H, Yuan M, Li J, Song K, Huang J . Madecassoside Protects Against LPS-Induced Acute Lung Injury Inhibiting TLR4/NF-κB Activation and Blood-Air Barrier Permeability. Front Pharmacol. 2020; 11:807. PMC: 7289980. DOI: 10.3389/fphar.2020.00807. View

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157:107843. DOI: 10.1016/j.diabres.2019.107843. View

Wu W, Liu L, Zhu H, Sun Y, Wu Y, Liao H . Butyrolactone-I, an efficient α-glucosidase inhibitor, improves type 2 diabetes with potent TNF-α-lowering properties through modulating gut microbiota in db/db mice. FASEB J. 2019; 33(11):12616-12629. PMC: 6902678. DOI: 10.1096/fj.201901061R. View

Nascimento J, Matheus V, Oliveira R, Tada S, Collares-Buzato C . High-Fat Diet Induces Disruption of the Tight Junction-Mediated Paracellular Barrier in the Proximal Small Intestine Before the Onset of Type 2 Diabetes and Endotoxemia. Dig Dis Sci. 2020; 66(10):3359-3374. DOI: 10.1007/s10620-020-06664-x. View

Zheng Y, Zhang J, Zhao Y, Zhang Y, Zhang X, Guan J . Curcumin protects against cognitive impairments in a rat model of chronic cerebral hypoperfusion combined with diabetes mellitus by suppressing neuroinflammation, apoptosis, and pyroptosis. Int Immunopharmacol. 2021; 93:107422. DOI: 10.1016/j.intimp.2021.107422. View

10.

Zhao L, Lou H, Peng Y, Chen S, Fan L, Li X . Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota. Diabetes Res Clin Pract. 2020; 169:108418. DOI: 10.1016/j.diabres.2020.108418. View

11.

Percie du Sert N, Ahluwalia A, Alam S, Avey M, Baker M, Browne W . Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 2020; 18(7):e3000411. PMC: 7360025. DOI: 10.1371/journal.pbio.3000411. View

12.

Tian J, Zhao Y, Wang L, Li L . Role of TLR4/MyD88/NF-κB signaling in heart and liver-related complications in a rat model of type 2 diabetes mellitus. J Int Med Res. 2021; 49(3):300060521997590. PMC: 8020098. DOI: 10.1177/0300060521997590. View

13.

Cani P, Bibiloni R, Knauf C, Waget A, Neyrinck A, Delzenne N . Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008; 57(6):1470-81. DOI: 10.2337/db07-1403. View

14.

Su H, Xie L, Xu Y, Ke H, Bao T, Li Y . Pelargonidin-3--glucoside Derived from Wild Raspberry Exerts Antihyperglycemic Effect by Inducing Autophagy and Modulating Gut Microbiota. J Agric Food Chem. 2019; 68(46):13025-13037. DOI: 10.1021/acs.jafc.9b03338. View

15.

Wang Y, Dilidaxi D, Wu Y, Sailike J, Sun X, Nabi X . Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice. Biomed Pharmacother. 2020; 125:109914. DOI: 10.1016/j.biopha.2020.109914. View

16.

Abdelsamia E, Khaleel S, Balah A, Baky N . Curcumin augments the cardioprotective effect of metformin in an experimental model of type I diabetes mellitus; Impact of Nrf2/HO-1 and JAK/STAT pathways. Biomed Pharmacother. 2018; 109:2136-2144. DOI: 10.1016/j.biopha.2018.11.064. View

17.

Jayashree B, Bibin Y, Prabhu D, Shanthirani C, Gokulakrishnan K, Lakshmi B . Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol Cell Biochem. 2013; 388(1-2):203-10. DOI: 10.1007/s11010-013-1911-4. View

18.

Zhang L, Chen X, Wang H, Huang H, Li M, Yao L . "Adjusting Internal Organs and Dredging Channel" Electroacupuncture Ameliorates Insulin Resistance in Type 2 Diabetes Mellitus by Regulating the Intestinal Flora and Inhibiting Inflammation. Diabetes Metab Syndr Obes. 2021; 14:2595-2607. PMC: 8200173. DOI: 10.2147/DMSO.S306861. View

19.

Pasini E, Corsetti G, Assanelli D, Testa C, Romano C, Dioguardi F . Effects of chronic exercise on gut microbiota and intestinal barrier in human with type 2 diabetes. Minerva Med. 2019; 110(1):3-11. DOI: 10.23736/S0026-4806.18.05589-1. View

20.

Feng W, Wang H, Zhang P, Gao C, Tao J, Ge Z . Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats. Biochim Biophys Acta Gen Subj. 2017; 1861(7):1801-1812. DOI: 10.1016/j.bbagen.2017.03.017. View